126 results
Page 3 of 7
8-K
EX-10.1
qvsnl7j7esk dsaazt
17 Jul 20
Entry into a Material Definitive Agreement
5:01pm
424B5
v45 l70cqhwomzl
17 Jul 20
Prospectus supplement for primary offering
5:01pm
8-K
EX-1.1
uxh470nzo11ftoevye0
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-10.1
2t5 1avyxid
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
424B5
kp5qfjh
20 May 20
Prospectus supplement for primary offering
4:03pm
424B5
knsl9 dkjnhj0fv5
20 May 20
Prospectus supplement for primary offering
4:02pm
424B5
c51ad b62s
18 May 20
Prospectus supplement for primary offering
4:02pm
424B5
zanlk
31 Mar 20
Prospectus supplement for primary offering
7:03am
8-K
EX-10.1
bb18bm fswn9vs2rvkbz
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
S-8
524lhtjmhu89baqdlf9
7 Jun 19
Registration of securities for employees
8:24am
S-8
r70g54cnqo7w55s
14 Mar 19
Registration of securities for employees
8:29am